Table 7.
Base case cost-effectiveness results of the salt substitution strategies from the cost-effectiveness model, Vietnam
| Strategy | Cost | IncrementalCost | Strokes avoided | IHD events avoided | QALYs gained | Incremental Effectiveness | ICER |
|---|---|---|---|---|---|---|---|
| No intervention | 1,053,481 ₫ (US$ 45.39) | – | – | – | 13.33 | – | – |
| Voluntary | 1,050,036 ₫ (US$ 45.24) | −3445 ₫ (−US$ 0.15) | 32,595 | 22,830 | 13.34 | 0.009 | DOMINANT |
| Subsidised | 1,010,292 ₫ (US$ 43.53) | −43,189 ₫ (−US$ 1.86) | 768,384 | 537,157 | 13.35 | 0.022 | DOMINANT |
| Regulatory | 809,951 ₫ (US$ 34.90) | −243,530 ₫ (−US$ 10.49) | 236,6480 | 1,648,590 | 13.41 | 0.074 | DOMINANT |
Abbreviations: ICER incremental cost-effectiveness ratio, IHD ischaemic heart disease, QALY quality adjusted life year